Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021

SELL
$4.03 - $7.57 $91,884 - $172,596
-22,800 Closed
0 $0
Q4 2020

Feb 03, 2021

BUY
$5.29 - $9.1 $120,612 - $207,480
22,800 New
22,800 $174,000
Q1 2020

May 06, 2020

SELL
$4.06 - $11.0 $46,283 - $125,400
-11,400 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$9.77 - $17.08 $111,378 - $194,711
11,400 New
11,400 $148,000

About LogicBio Therapeutics, Inc.


  • Ticker LOGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,962,700
  • Description
  • LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...
More about LOGC
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.